Peter S. Kim, Director at Entrada Therapeutics, Inc. (TRDA), bought 9,048 shares at $13.76 ($123K) on 2024-03-22, disclosed to the SEC on 2024-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.76 | 3,118 | $43K | 34.9% |
| 2 | $13.36 | 3,180 | $42K | 34.6% |
| 3 | $13.64 | 2,750 | $38K | 30.5% |
| Total | $13.58 avg | 9,048 | $123K | 100% |
| Filing → |
| TRDA | BUY | 2024-05-10 | $63K | — | Filing → |
| TRDA | BUY | 2024-04-10 | $35K | — | Filing → |
| TRDA | BUY | 2024-04-01 | $21K | — | Filing → |